Location History:
- Rohnert Park, CA (US) (2001)
- Villiston, VT (US) (2002)
- San Diego, CA (US) (2006)
Company Filing History:
Years Active: 2001-2006
Title: Pu Chen: Innovator in Glaucoma Research
Introduction
Pu Chen is a notable inventor based in San Diego, CA. He has made significant contributions to the field of glaucoma research, holding a total of 3 patents. His work focuses on the diagnosis, prognosis, and treatment of glaucoma and related disorders.
Latest Patents
One of Pu Chen's latest patents involves nucleic acids, kits, and methods for diagnosing, prognosing, and treating glaucoma. This invention highlights the use of upstream sequences of the TIGR protein encoding sequence to diagnose sensitivity to steroids and assess the risk for glaucoma or ocular hypertensive disorders. The patent also includes methods, kits, and nucleic acids that contain polymorphisms, base substitutions, or base additions located within the upstream region and protein-encoding regions of the TIGR gene. Furthermore, the disclosed upstream sequences, including the TIGR promoter regions, can be utilized to generate cells, vectors, and nucleic acids that are useful in various diagnostic and therapeutic applications.
Career Highlights
Pu Chen is affiliated with the University of California, where he continues to advance his research in the field of glaucoma. His innovative work has the potential to significantly impact the diagnosis and treatment of this prevalent eye condition.
Collaborations
Pu Chen collaborates with esteemed colleagues such as Thai D Nguyen and Jon R Polansky, contributing to a dynamic research environment focused on improving patient outcomes in glaucoma care.
Conclusion
Pu Chen's contributions to glaucoma research through his patents and collaborations underscore his commitment to advancing medical science. His work is paving the way for innovative diagnostic and therapeutic solutions in the field of ophthalmology.